Myosin-IIA S1943 phosphorylation as a marker of tumor invasion
View Patent ↗Methods and kits are provided for determining if cells of a tumor in an organ or a tissue in a subject are likely to invade another organ or tissue in the subject and for determining if a cancer in a subject is likely to metastasize.
1. A method for determining if cells of a tumor in an organ or in a tissue in a subject, are likely to invade another organ or tissue in the subject comprising determining if a sample of the tumor, or a sample obtained from the tumor, comprises human myosin-IIA heavy chain phosphorylated at residue S1943, comprising contacting the sample of the tumor, or the sample obtained from the tumor, with a detectable agent which comprises an antibody or an antigen-binding fragment of an antibody, which selectively binds to phosphorylated S1943 residue of human myosin-IIA heavy chain and detecting any bound detectable agent,
wherein cells of the tumor are likely to invade another organ or tissue if the sample comprises the phosphorylated S1943 residue of human myosin-IIA heavy chain, and wherein absence of a phosphorylated S1943 residue of human myosin-IIA heavy chain does not indicate that cells of the tumor are likely to invade another organ or tissue.
2. The method of claim 1 , wherein the human myosin-IIA heavy chain comprises SEQ ID NO:1.
3. The method of claim 1 , wherein the detectable agent is an antibody.
4. The method of claim 3 , wherein the antibody is labeled with a detectable label.
5. The method of claim 4 , wherein the detectable label is fluorescent, is radioactive, or is radio-opaque.
6. The method of claim 1 , wherein the phosphorylated S1943 residue of the human myosin-IIA heavy chain is detected on the surface of a cell of the sample.
7. The method of claim 1 , wherein the sample obtained from the tumor is not a lysate.
8. The method of claim 1 , wherein the tumor is a breast cancer tumor.
9. A method for determining if a cancer is likely to metastasize comprising determining if a sample of the cancer, or a sample obtained from the cancer, comprises human myosin-IIA heavy chain phosphorylated at residue S1943 comprising contacting the sample of the cancer, or the sample obtained from the cancer, with a detectable agent which comprises an antibody or an antigen-binding fragment of an antibody which selectively binds to phosphorylated S1943 residue of myosin-IIA heavy chain and detecting any bound detectable agent,
wherein the cancer is likely to metastasize if the sample comprises the phosphorylated S1943 residue of human myosin-IIA heavy chain.